<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
Background Image

MuPrime™ Tumor Microarrays (TMAs)

Revolutionizing Cancer Research with MuPrime™ TMAs

At Crown Bioscience, our MuPrime™ Tumor Microarrays (TMAs) are designed to provide researchers with high-quality, homogeneous tumor samples for comprehensive cancer research. These TMAs facilitate high-throughput analysis, essential for biomarker discovery, drug target validation, and translational studies.

 

Why Choose MuPrime™ TMAs?

  • Uniformity and Quality: Homogeneous tumor samples ensure reliable and reproducible results.
  • High-Throughput Analysis: Enables efficient large-scale studies across various cancer types.
  • Essential for Research: Crucial for the discovery of novel biomarkers and validation of therapeutic targets.

Current Availability:

  • Our MuPrime™ tumor microarrays are currently sold out. Stay tuned for new product releases.

For more information or to discuss your research needs, please contact us.

Related Services

akoya-sample-image

Digital Pathology Services

Advanced Pathology Services for Fast, Reliable Data: Histopathology, IHC, IF, and In Situ Hybridization with Automated Precision

NanostringServices_banner

Nanostring Spatial Transcriptomics and Proteomics Services

Explore the complete transcriptome and over 570 protein targets individually or in tandem, utilizing a range of sample inputs including whole tissue sections, tissue microarrays (TMAs), or organoids.